Page 1 of Clinical Trials for Biological Placebo, 1944 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers
Last Updated: April 8, 2011
Condition(s): Prevention of Infection With HIV-1
2
Active, not recruiting
Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants
Last Updated: November 3, 2011
Condition(s): Rotavirus Gastroenteritis
3
Completed
Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants
Last Updated: January 27, 2011
Condition(s): Rotavirus Gastroenteritis
4
Completed
Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma
Last Updated: July 11, 2011
Condition(s): Nasal Polyposis; Asthma
5
Completed
Double-Blind Randomized Placebo-Controlled Trial on Clinical and Biological Effects of Oral Corticosteroids or Doxycyclin in Patients With Nasal Polyposis
Last Updated: December 19, 2007
Condition(s): Nasal Polyposis
6
Completed
Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African Infants
Last Updated: February 9, 2012
Condition(s): Gastroenteritis Caused by Rotavirus; Prophylaxis Rotavirus
7
Recruiting
PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy
Last Updated: October 7, 2011
Condition(s): Actinic Keratosis
8
Completed
A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years
Last Updated: April 7, 2011
Condition(s): Human Papillomavirus (HPV) Infection; Associated Cervical Neoplasia; Papillomavirus Vaccines
9
Withdrawn
Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis
Last Updated: June 23, 2011
Condition(s): Plaque Psoriasis
10
Active, not recruiting
Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age
Last Updated: October 27, 2011
Condition(s): Cervical Cancer; Papillomavirus Infection
11
Not yet recruiting
A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers
Last Updated: January 23, 2012
Condition(s): HIV Infections
12
Recruiting
The Biology of Resilience
Last Updated: June 23, 2011
Condition(s): Oxytocin; Placebo
13
Recruiting
Dose-Response Study of Iocide Oral Rinse
Last Updated: August 22, 2011
Condition(s): Gingivitis
14
Completed
Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women
Last Updated: March 17, 2011
Condition(s): Cervical Cancer; Papillomavirus Infection
15
Completed
Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years
Last Updated: March 17, 2011
Condition(s): Human Papillomavirus (HPV) Infection; Associated Cervical Neoplasia; Papillomavirus Vaccines
16
Completed
Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC
Last Updated: September 30, 2010
Condition(s): Crohn Disease
17
Active, not recruiting
A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)
Last Updated: January 13, 2012
Condition(s): Arthritis, Rheumatoid
18
Completed
Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly
Last Updated: February 17, 2011
Condition(s): Influenza Infection
19
Completed
Study of KB003 In Biologics-Inadequate Rheumatoid Arthritis
Last Updated: January 3, 2012
Condition(s): Rheumatoid Arthritis
20
Completed
Phase 2 Study of MM-093 to Treat Patients With Uveitis
Last Updated: December 16, 2008
Condition(s): Uveitis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Biological+Placebo

Page 1 of Clinical Trials for Biological Placebo, 1944 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About